Document is current
Any future updates will be listed below
-
Authors
Raasveld, Floris V.
Hanna, Tareq
Pacheco, Fernando J.
Gonzalez, Marcos R.
Johnston, Benjamin
Lozano-Calderón, Santiago A.
Valerio, Ian L.
Eberlin, Kyle R.
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 18 February 2025
First Online: 9 March 2025
Disclosure
: Santiago A. Lozano-Calderón is a consultant for Onkos Inc., IlluminOss Inc., Bone Support, and Johnson & Johnson Inc., and a paid speaker for Carbofix and Amgen. Ian L. Valerio is a consultant for AxoGen Inc, Checkpoint Surgical Inc, and Integra Lifesciences Inc. Kyle R. Eberlin is a consultant for AxoGen Inc, Checkpoint Surgical Inc., Integra Lifesciences Inc., Tissium, Tulavi Therapeutics Inc., and Biocircuit. Floris V. Raasveld, Tareq Hanna, Fernando J. Pacheco, Marcos R. Gonzalez, and Benjamin Johnston have no disclosures to declare that may be relevant to the contents of this study.
